Dyadic International (DYAI) Payables (2017 - 2026)
Dyadic International's (DYAI) quarterly Payables came in at $1.1 million in Q1 2026, up 136.42% year-over-year from $448390.0 in Q1 2025, and up 24.42% quarter-over-quarter from $852024.0 in Q4 2025.
Analysis
Dyadic International (DYAI) Payables (2017 - 2026) Analysis & Trends
Dyadic International has disclosed Payables across 10 years of filings, most recently posting $1.1 million for Q1 2026.
- In Q1 2026, Payables rose 136.42% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 136.42% YoY), while the FY2025 annual figure was $852024.0, up 76.65% from the prior year.
- Payables came in at $1.1 million for Q1 2026 at Dyadic International, up from $852024.0 in the prior quarter.
- In the past five years, Payables ranged from a high of $866.3 million in Q1 2022 to a low of $432521.0 in Q2 2024.
- Average Payables over 5 years is $51.7 million, with a median of $770371.0 recorded in 2023.
- Year-over-year, Payables jumped 58680.93% in 2022 and plunged 99.91% in 2023.
- Over 5 years, Payables stood at $1.3 million in 2022, then plunged by 48.57% to $656445.0 in 2023, then dropped by 26.53% to $482320.0 in 2024, then surged by 76.65% to $852024.0 in 2025, then gained by 24.42% to $1.1 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $1.1 million in Q1 2026, $852024.0 in Q4 2025, and $1.2 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | 25.08 Mn |
| 10 | Dyadic International | 17.65 Mn | 9.69 Mn | - | 1.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 852,024.00 |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 738,794.00 |
| Mar 31, 2025 | 448,390.00 |
| Dec 31, 2024 | 482,320.00 |
| Sep 30, 2024 | 561,797.00 |
| Jun 30, 2024 | 432,521.00 |
| Mar 31, 2024 | 661,243.00 |
| Dec 31, 2023 | 656,445.00 |
| Sep 30, 2023 | 600,148.00 |
| Jun 30, 2023 | 905,876.00 |
| Mar 31, 2023 | 770,371.00 |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 777,238.00 |
| Jun 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 866.32 Mn |
| Dec 31, 2021 | 1.55 Mn |
| Sep 30, 2021 | 957,802.00 |
| Jun 30, 2021 | 2.43 Mn |